Differential regulation of mTOR activity in retinal ganglion cells underlies their distinct susceptibility to ischemia/reperfusion

Commun Biol. 2025 Jun 11;8(1):911. doi: 10.1038/s42003-025-08314-2.

Abstract

Retinal ischemia/reperfusion (I/R) injury drives progressive retinal ganglion cell (RGC) loss, yet mechanisms underlying neuronal type-specific vulnerability remain unclear. Using a mouse model of bilateral common carotid artery ligation, we observe decreased vessel density in the inner retina following I/R. Here, the total RGCs exhibit much more cell loss than the intrinsic photosensitive RGCs (ipRGCs). This disparity is parallel with their different mTOR activity: for ipRGCs, the mTOR activity is much higher than the total RGCs both before and after I/R. Pharmacological experiments reveal that, mTOR activation in total RGCs and high mTOR activity maintenance in ipRGCs promote rapamycin to protect the total RGCs and ipRGCs against I/R injury, respectively. Notably, the protective effects of rapamycin on total RGCs and ipRGCs manifest under different light conditions. Our findings bridge the type-specific mTOR regulation in RGCs and their distinct susceptibility to I/R injury, which offers new insights into further targeted neuroprotection.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Reperfusion Injury* / metabolism
  • Reperfusion Injury* / pathology
  • Retinal Ganglion Cells* / drug effects
  • Retinal Ganglion Cells* / metabolism
  • Retinal Ganglion Cells* / pathology
  • Sirolimus / pharmacology
  • TOR Serine-Threonine Kinases* / genetics
  • TOR Serine-Threonine Kinases* / metabolism

Substances

  • TOR Serine-Threonine Kinases
  • mTOR protein, mouse
  • Sirolimus